Characterization of specific binding sites for α-trinositol (d-myo-inositol 1,2,6-trisphosphate) in rat tissues

Heahyun Yoo, Bo Fallgren, Anneli Lindahl, Claes R Wahlestedt

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Alfa-trinositol (or d-myo-inositol 1,2,6-trisphosphate) was recently found to, e.g., inhibit agonist-induced vasoconstriction and display antiinflammatory properties. However, its mechanism of action is unknown, although effects on Ca2+ fluxes, perhaps by interfering with endogenous inositol phosphate(s), have been suggested. Here we describe the existence of specific [3H]α-trinositol binding sites and compare these with binding sites for naturally occurring inositol phosphates. For this purpose we developed a tritiated analog of α-trinositol and used it in a centrifugation binding assay on extensively washed membranes from rat tissues. The degree of specific [3H]α-trinositol binding was markedly increased as a result of the many wash steps, indicating the existence of endogenous binding inhibitor(s). A single population of [3H]α-trinositol binding sites, displaying a KD of 159 nM and a Bmax of 71 pmol/mg protein, was present in cardiac membranes assayed at pH 7.4. Similar binding site densities were detected also in liver > lung > brain. The relative density of [3H]α-trinositol sites in cardiac membranes was 8-fold higher than [3H]Ins(1,4,5)P3 but 2-fold and 4-fold lower than [3H]Ins(1,3,4,5)P4 and [3H]InsP6 binding sites, respectively. Competition binding studies indicated the ability of Ins(1,3,4,5)P4 and InsP6, but not Ins(1,4,5)P3, to potently displace [3H]α-trinositol binding. Conversely, unlabelled α-trinositol showed relatively low potency vs. [3H]InsP6, but the novel inositol phosphate was virtually equipotent with Ins(1,3,4,5)P4 in inhibiting [3H]Ins(1,3,4,5)P4 binding. Finally, analyses of binding at different pH and ionic conditions revealed differences between α-trinositol and the three other previously studied inositol phosphates, although distinct similarities between α-trinositol and Ins(1,3,4,5)P4 were again observed.

Original languageEnglish
Pages (from-to)55-63
Number of pages9
JournalEuropean Journal of Pharmacology: Molecular Pharmacology
Volume268
Issue number1
DOIs
StatePublished - Jun 15 1994
Externally publishedYes

Fingerprint

Inositol
Inositol Phosphates
Binding Sites
Membranes
Specific Gravity
Vasoconstriction
Centrifugation
Anti-Inflammatory Agents
inositol-1,3,4,5-tetrakisphosphate
Lung
Liver
Brain
Population
Proteins

Keywords

  • Binding site
  • Heart
  • Inositol phosphate
  • α-Trinositol

ASJC Scopus subject areas

  • Pharmacology

Cite this

Characterization of specific binding sites for α-trinositol (d-myo-inositol 1,2,6-trisphosphate) in rat tissues. / Yoo, Heahyun; Fallgren, Bo; Lindahl, Anneli; Wahlestedt, Claes R.

In: European Journal of Pharmacology: Molecular Pharmacology, Vol. 268, No. 1, 15.06.1994, p. 55-63.

Research output: Contribution to journalArticle

@article{832f902bdbe14295bce73d458bea8918,
title = "Characterization of specific binding sites for α-trinositol (d-myo-inositol 1,2,6-trisphosphate) in rat tissues",
abstract = "Alfa-trinositol (or d-myo-inositol 1,2,6-trisphosphate) was recently found to, e.g., inhibit agonist-induced vasoconstriction and display antiinflammatory properties. However, its mechanism of action is unknown, although effects on Ca2+ fluxes, perhaps by interfering with endogenous inositol phosphate(s), have been suggested. Here we describe the existence of specific [3H]α-trinositol binding sites and compare these with binding sites for naturally occurring inositol phosphates. For this purpose we developed a tritiated analog of α-trinositol and used it in a centrifugation binding assay on extensively washed membranes from rat tissues. The degree of specific [3H]α-trinositol binding was markedly increased as a result of the many wash steps, indicating the existence of endogenous binding inhibitor(s). A single population of [3H]α-trinositol binding sites, displaying a KD of 159 nM and a Bmax of 71 pmol/mg protein, was present in cardiac membranes assayed at pH 7.4. Similar binding site densities were detected also in liver > lung > brain. The relative density of [3H]α-trinositol sites in cardiac membranes was 8-fold higher than [3H]Ins(1,4,5)P3 but 2-fold and 4-fold lower than [3H]Ins(1,3,4,5)P4 and [3H]InsP6 binding sites, respectively. Competition binding studies indicated the ability of Ins(1,3,4,5)P4 and InsP6, but not Ins(1,4,5)P3, to potently displace [3H]α-trinositol binding. Conversely, unlabelled α-trinositol showed relatively low potency vs. [3H]InsP6, but the novel inositol phosphate was virtually equipotent with Ins(1,3,4,5)P4 in inhibiting [3H]Ins(1,3,4,5)P4 binding. Finally, analyses of binding at different pH and ionic conditions revealed differences between α-trinositol and the three other previously studied inositol phosphates, although distinct similarities between α-trinositol and Ins(1,3,4,5)P4 were again observed.",
keywords = "Binding site, Heart, Inositol phosphate, α-Trinositol",
author = "Heahyun Yoo and Bo Fallgren and Anneli Lindahl and Wahlestedt, {Claes R}",
year = "1994",
month = "6",
day = "15",
doi = "10.1016/0922-4106(94)90119-8",
language = "English",
volume = "268",
pages = "55--63",
journal = "European Journal of Pharmacology - Molecular Pharmacology Section",
issn = "0922-4106",
publisher = "Elsevier BV",
number = "1",

}

TY - JOUR

T1 - Characterization of specific binding sites for α-trinositol (d-myo-inositol 1,2,6-trisphosphate) in rat tissues

AU - Yoo, Heahyun

AU - Fallgren, Bo

AU - Lindahl, Anneli

AU - Wahlestedt, Claes R

PY - 1994/6/15

Y1 - 1994/6/15

N2 - Alfa-trinositol (or d-myo-inositol 1,2,6-trisphosphate) was recently found to, e.g., inhibit agonist-induced vasoconstriction and display antiinflammatory properties. However, its mechanism of action is unknown, although effects on Ca2+ fluxes, perhaps by interfering with endogenous inositol phosphate(s), have been suggested. Here we describe the existence of specific [3H]α-trinositol binding sites and compare these with binding sites for naturally occurring inositol phosphates. For this purpose we developed a tritiated analog of α-trinositol and used it in a centrifugation binding assay on extensively washed membranes from rat tissues. The degree of specific [3H]α-trinositol binding was markedly increased as a result of the many wash steps, indicating the existence of endogenous binding inhibitor(s). A single population of [3H]α-trinositol binding sites, displaying a KD of 159 nM and a Bmax of 71 pmol/mg protein, was present in cardiac membranes assayed at pH 7.4. Similar binding site densities were detected also in liver > lung > brain. The relative density of [3H]α-trinositol sites in cardiac membranes was 8-fold higher than [3H]Ins(1,4,5)P3 but 2-fold and 4-fold lower than [3H]Ins(1,3,4,5)P4 and [3H]InsP6 binding sites, respectively. Competition binding studies indicated the ability of Ins(1,3,4,5)P4 and InsP6, but not Ins(1,4,5)P3, to potently displace [3H]α-trinositol binding. Conversely, unlabelled α-trinositol showed relatively low potency vs. [3H]InsP6, but the novel inositol phosphate was virtually equipotent with Ins(1,3,4,5)P4 in inhibiting [3H]Ins(1,3,4,5)P4 binding. Finally, analyses of binding at different pH and ionic conditions revealed differences between α-trinositol and the three other previously studied inositol phosphates, although distinct similarities between α-trinositol and Ins(1,3,4,5)P4 were again observed.

AB - Alfa-trinositol (or d-myo-inositol 1,2,6-trisphosphate) was recently found to, e.g., inhibit agonist-induced vasoconstriction and display antiinflammatory properties. However, its mechanism of action is unknown, although effects on Ca2+ fluxes, perhaps by interfering with endogenous inositol phosphate(s), have been suggested. Here we describe the existence of specific [3H]α-trinositol binding sites and compare these with binding sites for naturally occurring inositol phosphates. For this purpose we developed a tritiated analog of α-trinositol and used it in a centrifugation binding assay on extensively washed membranes from rat tissues. The degree of specific [3H]α-trinositol binding was markedly increased as a result of the many wash steps, indicating the existence of endogenous binding inhibitor(s). A single population of [3H]α-trinositol binding sites, displaying a KD of 159 nM and a Bmax of 71 pmol/mg protein, was present in cardiac membranes assayed at pH 7.4. Similar binding site densities were detected also in liver > lung > brain. The relative density of [3H]α-trinositol sites in cardiac membranes was 8-fold higher than [3H]Ins(1,4,5)P3 but 2-fold and 4-fold lower than [3H]Ins(1,3,4,5)P4 and [3H]InsP6 binding sites, respectively. Competition binding studies indicated the ability of Ins(1,3,4,5)P4 and InsP6, but not Ins(1,4,5)P3, to potently displace [3H]α-trinositol binding. Conversely, unlabelled α-trinositol showed relatively low potency vs. [3H]InsP6, but the novel inositol phosphate was virtually equipotent with Ins(1,3,4,5)P4 in inhibiting [3H]Ins(1,3,4,5)P4 binding. Finally, analyses of binding at different pH and ionic conditions revealed differences between α-trinositol and the three other previously studied inositol phosphates, although distinct similarities between α-trinositol and Ins(1,3,4,5)P4 were again observed.

KW - Binding site

KW - Heart

KW - Inositol phosphate

KW - α-Trinositol

UR - http://www.scopus.com/inward/record.url?scp=0028243937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028243937&partnerID=8YFLogxK

U2 - 10.1016/0922-4106(94)90119-8

DO - 10.1016/0922-4106(94)90119-8

M3 - Article

VL - 268

SP - 55

EP - 63

JO - European Journal of Pharmacology - Molecular Pharmacology Section

JF - European Journal of Pharmacology - Molecular Pharmacology Section

SN - 0922-4106

IS - 1

ER -